£92.41

CRC Press Noninvasive Molecular Markers in Gynecologic Cancers - CRC Press

9781466569386

Price data checked 4 days ago

View at Amazon

Price History & Forecast

Last 87 days • 87 data points (No recent data available)

Historical
Generating forecast...
£92.95 £86.55 £87.94 £89.34 £90.74 £92.14 £93.53 28 January 2026 18 February 2026 12 March 2026 02 April 2026 24 April 2026

Price Distribution

Price distribution over 87 days • 7 price levels

Days at Price
Current Price
7 days 3 days 3 days 21 days 41 days 7 days · current 5 days 0 10 21 31 41 £87 £88 £89 £90 £91 £92 £93 Days at Price

Price Analysis

Most common price: £91 (41 days, 47.1%)

Price range: £87 - £93

Price levels: 7 different prices over 87 days

Description

Early detection is a vital component in cancer management. As omics technologies advance, molecular markers are becoming essential tools when used alongside traditional diagnostic and screening methods. This resource explores how these next-generation strategies facilitate early-stage diagnosis, which leads to more effective treatment and improved patient care. By identifying markers early, medical professionals can work toward increasing survival rates for patients. Noninvasive Molecular Markers in Gynecologic Cancers serves as a comprehensive guide for those studying the latest developments in the field. The text provides detailed information on noninvasive molecular diagnostic biomarkers and covers essential topics such as epidemiology and clinical applications. This book is designed to be a ready-made resource for medical practitioners and researchers looking to understand the role of molecular markers in gynecologic oncology.

Key Features

Provides detailed information on noninvasive molecular diagnostic biomarkers to support early-stage diagnosis and patient care.

Explores the integration of the latest omics technologies with conventional diagnostic and screening methods.

Includes comprehensive coverage of epidemiology and clinical applications related to gynecologic cancers.

Offers insights into next-generation prognostic strategies to help improve treatment effectiveness and survival rates.

Serves as a ready-made resource for professionals needing updated data on molecular markers in oncology.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis
97% match

Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis

CRC Press

£103.58 17 Feb 2026
Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis
97% match

Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis

CRC Press

£146.42 12 Jan 2026
Research on New Generation Tumor Markers - Nova Science Publishers
95% match

Research on New Generation Tumor Markers - Nova Science Publishers

£152.92 25 Apr 2026
Molecular Biomarkers for Cancer Diagnosis and Therapy
95% match

Molecular Biomarkers for Cancer Diagnosis and Therapy

Springer

£121.71 29 Jan 2026
CRC Press - Prognostic and Predictive Factors in Gynecologic Cancers
94% match

CRC Press - Prognostic and Predictive Factors in Gynecologic Cancers

CRC Press

£18.39 26 Apr 2026
Cancer Biomarkers (Cancer Etiology, Diagnosis and Treatments)
94% match

Cancer Biomarkers (Cancer Etiology, Diagnosis and Treatments)

£16.21 08 Mar 2026
Ovarian Cancer Biomarkers: Mapping to Improve Outcomes
94% match

Ovarian Cancer Biomarkers: Mapping to Improve Outcomes

Springer

£103.30 02 Apr 2026
Cancer Biomarkers: Clinical Aspects and Laboratory Determination
94% match

Cancer Biomarkers: Clinical Aspects and Laboratory Determination

Elsevier

£109.37 09 Mar 2026
Illuminating Colorectal Cancer Genomics by Next-Generation Sequencing: A Big Chapter in the Tale
94% match

Illuminating Colorectal Cancer Genomics by Next-Generation Sequencing: A Big Chapter in the Tale

Springer

£121.12 22 Apr 2026
Illuminating Colorectal Cancer Genomics by Next-Generation Sequencing: A Big Chapter in the Tale
94% match

Illuminating Colorectal Cancer Genomics by Next-Generation Sequencing: A Big Chapter in the Tale

Springer

£116.58 10 Feb 2026
Biomarkers in Breast Cancer (Cancer Drug Discovery and Development)
94% match

Biomarkers in Breast Cancer (Cancer Drug Discovery and Development)

Humana

£144.17 12 Jan 2026
Cancer Biomarkers in Diagnosis and Therapeutics
94% match

Cancer Biomarkers in Diagnosis and Therapeutics

£118.00 13 Jan 2026
Cancer Biomarkers in Body Fluids: Principles
94% match

Cancer Biomarkers in Body Fluids: Principles

Springer

£109.24 09 Mar 2026
CRC Press Cancer Biomarkers - Molecular Marker Research Book
94% match

CRC Press Cancer Biomarkers - Molecular Marker Research Book

CRC Press

£125.00 08 Apr 2026
Research Progress in Tumor Markers
94% match

Research Progress in Tumor Markers

£47.40 27 Apr 2026
Histological and Serological Tumor Markers and Gene Expression and Their Clinical Usefulness in Cancers
94% match

Histological and Serological Tumor Markers and Gene Expression and Their Clinical Usefulness in Cancers

£115.52 14 Feb 2026
Molecular Pathology of Breast Cancer
94% match

Molecular Pathology of Breast Cancer

Springer

£114.75 25 Jan 2026
Ovarian Cancer Biomarkers: Mapping to Improve Outcomes
94% match

Ovarian Cancer Biomarkers: Mapping to Improve Outcomes

Springer

£80.65 06 Mar 2026
Methods of Cancer Diagnosis, Therapy and Prognosis: Colorectal Cancer: 4
94% match

Methods of Cancer Diagnosis, Therapy and Prognosis: Colorectal Cancer: 4

Springer

£213.13 24 Jan 2026
Springer - Cancer Biomarkers in Body Fluids: Principles
94% match

Springer - Cancer Biomarkers in Body Fluids: Principles

Springer

£113.09 26 Apr 2026
Springer - Predictive Biomarkers in Oncology Book
94% match

Springer - Predictive Biomarkers in Oncology Book

Springer

£117.77 23 Apr 2026
Humana Melanoma Biomarkers and Therapeutic Targets Book
94% match

Humana Melanoma Biomarkers and Therapeutic Targets Book

Humana

£64.90 29 Mar 2026
Hereditary Gynecologic Cancer: Risk, Prevention and Management
94% match

Hereditary Gynecologic Cancer: Risk, Prevention and Management

CRC Press

£185.00 23 Jan 2026
Methods of Cancer Diagnosis, Therapy, and Prognosis: Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine ... Leukemia, Multiple Myeloma and Sarcoma: 6
94% match

Methods of Cancer Diagnosis, Therapy, and Prognosis: Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine ... Leukemia, Multiple Myeloma and Sarcoma: 6

Springer

£165.82 14 Jan 2026